NIH Clinical Center Search the Studies: Study Number, Study Title

Protocol Details

Characterization and Treatment of Adolescent Depression

This study is currently recruiting participants.

Summary | Eligibility | Citations | Contacts

Summary

Number

18-M-0037

Sponsoring Institute

National Institute of Mental Health (NIMH)

Recruitment Detail

Type: Participants currently recruited/enrolled
Gender: Male & Female
Min Age: 11 Years
Max Age: 25 Years

Referral Letter Required

No

Population Exclusion(s)

None

Keywords

Cognitive Behavior Therapy;
Mood Disorder;
Biomarkers;
Mechanism;
Major Depressive Disorder (MDD);
Natural History

Recruitment Keyword(s)

None

Condition(s)

Depression

Investigational Drug(s)

None

Investigational Device(s)

None

Intervention(s)

Behavioral: Growth Mindset

Supporting Site

National Institute of Mental Health

This research study seeks to find causes and treatments of depression in teenagers. The study goals are to increase our knowledge of treatments for depression and understand how the brain changes when teenagers have depression. The study will also compare teenagers with depression to those without mental health diagnoses.

This outpatient study is recruiting participants ages 11-17 who are depressed. They must have a pediatrician or other medical provider, be medically healthy, and able to perform research tasks. They may not currently be hospitalized, psychotic or actively suicidal. Teenagers with depression are eligible even if they are taking medication.

The study begins with an evaluation that includes clinical assessment, interviews, and questionnaires.

-Visits may include paper-and-pencil and computer tests of mood, memory, and thinking; specialized computer games; and structural and brain imaging. If eligible, study participants may return several times a year for up to two years. This part of the study does not involve treatment.

-Participants may be eligible for outpatient treatment for up to 25 weeks. This includes evidenced-based "talk" therapy. Participants may choose either Interpersonal Psychotherapy for Adolescents (IPT-A) or Cognitive Behavioral Therapy (CBT). If indicated, participants may opt to receive standard medication treatments along with psychotherapy. Research includes computer tasks and brain imaging.

All clinical evaluations, research tasks and visits are free of cost. Participants are compensated for research activities. Parents and teenager must agree to the teenager s participation in research.

The study is conducted at the NIH in Bethesda, Maryland and enrolls participants from the Washington DC Metro region within 50 miles of NIH. Transportation expenses are reimbursed by NIMH.

--Back to Top--

Eligibility

INCLUSION CRITERIA:

-Youths who meet DSM 5 criteria for Major Depressive Disorder (Group 1)

Inclusion criteria for Youth with MDD (all must be met):

--Ages 11-17 at the time of enrollment in Characterization;

--Current diagnosis of DSM-5 Major Depressive Disorder (within the last six months from assessment) which are:

--Five or more of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure.

---Depressed mood most of the day, nearly every day, as indicated by either subjective report (e.g., feeling sad, blue, "down in the dumps,"or empty) or observation made by others (e.g., appears tearful or about to cry). (In children and adolescents, this may present as an irritable or cranky, rather than sad, mood.)

---Markedly diminished interest or pleasure in all, or almost all, activities every day, such as no interest in hobbies, sports, or other things the person used to enjoy doing.

---Significant weight loss when not dieting or weight gain (e.g., a change of more than 5 percent of body weight in a month) or decrease or increase in appetite nearly every day.

---Insomnia (inability to get to sleep or difficulty staying asleep) or hypersomnia (sleeping too much) nearly every day

---Psychomotor agitation (e.g., restlessness, inability to sit still, pacing, pulling at clothes or clothes) or retardation (e.g., slowed speech, movements, quiet talking) nearly every day

---Fatigue, tiredness, or loss of energy nearly every day (e.g., even the smallest tasks, like dressing or washing, seem difficult to do and take longer than usual).

---Feelings of worthlessness or excessive or inappropriate guilt nearly every day (e.g., ruminating over minor past failings).

---Diminished ability to think or concentrate, or indecisiveness, nearly every day (e.g. appears easily distracted, complains of memory difficulties).

---Recurrent thoughts of death (not just fear of dying), recurrent suicidal ideas without a specific plan, or a suicide attempt or a specific plan for committing suicide

--Symptoms cause clinically significant distress or impairment in social, occupational/academic, or other important areas of functioning.

--The episode is not attributable to the physiological effects of a substance or to another medical condition.

--Added criteria for Children with MDD entering outpatient treatment. In addition to criteria in above, the youth:

---Meets criteria for on-going or current (defined as within the past six weeks) MDD

--Criteria for entering treatment for Youth with Oscillating Depression plus Anxiety (YODA):

---In addition to above, those who met full criteria for MDD within the past six weeks, but are sub-threshold now, and in addition, meet ongoing full criteria for one or more of Social Phobia, Generalized Anxiety Disorder, Panic Disorder, or Separation Anxiety Disorder are termed YODA. YODA, who do not meet criteria for ongoing MDD, will be eligible for treatment. While YODA are sub-threshold for DSM-5 Major Depression at the time of enrollment into treatment studies, they must have met full criteria for MDD within the past six weeks.

-Youths who meet modified DSM criteria for Subthreshold Depression (Group 2) (This cohort is historical only; (previously n=200 to be enrolled; ceased enrolling this population with Amendment J (2022); none enrolled after Dec 2021).

--Inclusion criteria for subthreshold depressive disorder were:

---Ages 11-17 at the time of enrollment in Characterization;

---An episode of depressed mood or loss of interest or pleasure lasting at least 1 week plus

---At least two of the seven other DSM-5-associated symptoms for major depression

---Occurring in the last six months.

INCLUSION CRITERIA FOR HEALTHY VOLUNTEERS:

-Adolescent Healthy Volunteers (Group 3a)

--Youth 11 to 17 years of age at time of enrollment in Characterization

--the adolescent must be competent to assent; parents must be able comprehend and provide permission for their child (consent).

--Participants will be willing to participate in NIMH IRB approved research protocols. Minors will be asked to sign assent forms and their parents will sign the consent form.

--Participants will be willing to undergo an evaluation which may include a psychiatric interview, review of medical history (including Tanner staging for minors), and pregnancy testing.

--Speaks English.

--Have an identified primary care clinician.

-Adult Healthy Volunteers (Group 3b)

--Adults 18 to 30 years of age at time of enrollment in Characterization

--Subjects must be competent to consent.

--Participants will be willing to participate in NIMH IRB approved research protocols.

--Participants will be willing to undergo an evaluation, which may include a psychiatric interview, review of medical history, and pregnancy testing (for females).

--Speaks English.

--Has an identified primary care clinician.

INCLUSION CRITERIA FOR PARENTS OF ENROLLED YOUTH (Group 4):

--Are the biological parent or legal guardian of an enrolled adolescent (who is a healthy volunteer or has MDD) participant; Parents of those with s-MDD are historical only; none enrolled after Dec 2021.

--Those of all ages are eligible if they are a parent of a currently enrolled participant

EXCLUSION CRITERIA: (All patients)

-Exclusion Criteria for MDD patients (Group 1)

--Meets criteria for schizophrenia, schizophreniform disorder, schizoaffective illness, bipolar disorder, more than mild Autism Spectrum Disorder, Anorexia Nervosa or other severe Eating Disorder.

--Intellectual disability (clinically identified or IQ less than 70)

--For subjects with major depression or sub-threshold major depressive episode: Symptoms of depression are due to the direct physiological effects of a drug of abuse, or to a general medical or neurological condition by self and parent report.

--Meets DSM-5 criteria for alcohol or substance use disorder (excluding tobacco and nicotine use) within the last three months. This is determined solely by clinical interview of child and parent (e.g., KSADS).

--Current active suicidal ideation (i.e., presence of intent for engaging in suicidal behaviors).

Youths with passive suicidal ideation and/or past active suicidal ideation are still eligible.

--Participants with repeated self-harm occurring in the context of inter-personal conflict.

-- NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.

-Exclusion criteria for youths meeting modified DSM criteria for Subthreshold Depression (Group 2) (this cohort is historical only; previously n=200 to be enrolled; ceased enrolling this population with Amendment J (2022); none enrolled after Dec 2021):

--Intellectual disability (clinically identified or IQ less than 70).

--Any serious medical condition (such as epilepsy, heart disease requiring medication) by self and parent report.

--Past or current diagnosis of a manic or hypomanic episode, major depression), schizophrenia, schizophreniform disorder, schizoaffective illness, Tourette Disorder, or Autism Spectrum Disorder, Anorexia Nervosa or other severe Eating Disorder.

--Meets DSM-5 criteria for alcohol or substance abuse within the last three months by self and parent report.

--NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.

-Healthy volunteer youths and adults exclusion criteria:

--Intellectual disability (clinically identified or IQ less than 70).

--Any serious medical condition (such as epilepsy, heart disease requiring medication) by self and parent report.

--Past or current diagnosis of any mood disorder (manic or hypomanic episode, major depression), anxiety disorder (except specific phobia), Obsessive Compulsive Disorder (OCD), Post-Traumatic Stress Disorders (PTSD), Conduct Disorder, schizophrenia, schizophreniform disorder, schizoaffective illness, Tourette Disorder, or Autism Spectrum Disorder.

--Meets DSM-5 criteria for alcohol or substance abuse within the last three months by self and parent report; for adults, past history of substance dependency or substance abuse within the last three months by self-report.

--NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.

Parents of enrolled participants (group 3) exclusion criteria:

--Parents who are unable to understand or read English well enough to complete the study interview and tests.

--Parents who are a current NIMH employee, or staff member, or a family member of an NIMH employee. NIMH IRP Employees/staff and immediate family members will be excluded from the study per NIMH policy.


--Back to Top--

Citations:

Not Provided

--Back to Top--

Contacts:

Principal Investigator

Referral Contact

For more information:

Daniel S. Pine, M.D.
National Institute of Mental Health (NIMH)
NIHBC 15K - QUARTERS BG RM 110
15K NORTH DR
BETHESDA MD 20892
(301) 594-1318
daniel.pine@nih.gov

Daniel S. Pine, M.D.
National Institute of Mental Health (NIMH)
NIHBC 15K - QUARTERS BG RM 110
15K NORTH DR
BETHESDA MD 20892
(301) 594-1318
daniel.pine@nih.gov

Office of Patient Recruitment
National Institutes of Health Clinical Center (CC)
Building 61, 10 Cloister Court
Bethesda, Maryland 20892
Toll Free: 1-800-411-1222
Local Phone: 301-451-4383
TTY: TTY Users Dial 7-1-1
ccopr@nih.gov

Clinical Trials Number:

NCT03388606

--Back to Top--